Philip Morris exploits loopholes in Israeli smoking ad ban

Dec.16.2022
Philip Morris exploits loopholes in Israeli smoking ad ban
Philip Morris International used legal loopholes to advertise cigarettes and e-cigarettes in Israel, according to a new study.

According to a report by the Jerusalem Post, a new study has shown that Philip Morris International (PMI) has exploited a loophole in the ban on Israeli tobacco advertising.


A study published in the journal "Tobacco Control" analyzed PMI's advertising spending over four years amongst the general population, Haredi community, Arabic speakers, and Russian speakers.


Dr. Amal Khayat stated that due to regulatory changes in tobacco product advertisements, a comparison was made of advertising expenditures for all Philip Morris cigarette brands and the IQOS brand (a type of heated tobacco stick that entered the local market in December 2016).


According to the study, advertising restrictions resulted in decreased marketing expenses for PMI. However, the company exploited legal loopholes in print media.


Even after the law had taken effect, the company continued spending almost 3 million in new shekels (about 6.078 million yuan) on advertising, with a focus on print media, according to chief researcher Yael Bar-Zeev. "While the law limits print advertising to one ad per newspaper, 40% of IQOS ads are huge, two-page ads, effectively doubling the product's ad space while still being considered a single ad under the law.


PMI also utilized QR codes to allow consumers to scan and access more information. According to the study, prior to the implementation of this law, PMI significantly increased its advertising efforts targeting the Haredi community, who previously had the lowest smoking rates in Israel.


Our data shows that since the launch of IQOS electronic cigarettes, 216 targeted advertisements have been released, with 55% aimed at the Haredi community, 6% aimed at Arab communities, and the remainder aimed at Russian-speaking audiences," said Bazelevs CEO. For regular cigarette brands, 87% of advertisements are targeted at the Haredi community.


We expect the company to focus on the demographic of Arab men, who have the highest smoking rates in Israel, rather than a population with almost no smokers," Bar-Zeev said.


After conducting research, the 24th Parliament has decided to eliminate the exemption for printed media advertisements, however, the implementation of this decision has been delayed for seven years. During this period, the use of coupons, QR codes, and advertisements for cigarettes without mandatory non-decorated packaging will be prohibited in printed media.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia’s House of Delegates passed the Vape Safety Act of 2026, a proposal to tighten oversight of vape and smoke shops through licensing, fees and enforcement. The bill would establish a state directory requiring vape products sold in West Virginia to have FDA marketing authorization or a pending application under FDA review to be listed, and only directory-listed products could be sold starting Sept. 1, 2026 if enacted.
Feb.28 by 2FIRSTS.ai
KT&G Aims to Accelerate Launch of New Heated Tobacco Innovation Platform
KT&G Aims to Accelerate Launch of New Heated Tobacco Innovation Platform
KT&G Chief Executive Officer Bang Kyung-man said at the annual shareholders meeting on March 26 that although the company expects a challenging environment marked by stronger protectionism and a high exchange rate, it will continue on a stable growth path through strategic choice and focus.
Mar.26 by 2FIRSTS.ai
Scandinavian Tobacco Group releases 2025 results: tariffs and weaker demand weigh on performance, revenue about $1.4 billion
Scandinavian Tobacco Group releases 2025 results: tariffs and weaker demand weigh on performance, revenue about $1.4 billion
Scandinavian Tobacco Group (STG) reported its 2025 results: revenue was 9.036 billion Danish kroner (about $1.407 billion); EBITDA before special items was 1.791 billion Danish kroner (about $278 million); and free cash flow before acquisitions was 595 million Danish kroner (about $92.7 million). Multiple metrics declined year over year, and the company did not meet its Q3-updated guidance for revenue and free cash flow.
Mar.05 by 2FIRSTS.ai
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05
South Korea online purchasing fuels spread among younger groups; online drug cases share climbs
South Korea online purchasing fuels spread among younger groups; online drug cases share climbs
Police said detections of new drugs disguised as e-cigarettes reached 1,206 cases through September last year, up from 941 in 2022, and the number of detected drug types increased from 26 to 33 over the same period.
Feb.11 by 2FIRSTS.ai
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24